Literature DB >> 1310671

Detection of ciprofloxacin resistance in gram-negative bacteria due to alterations in gyrA.

E G Power1, J L Muñoz Bellido, I Phillips.   

Abstract

Two plasmids containing the cloned Escherichia coli wild-type gyrA gene were used to transform ciprofloxacin-resistant Gram-negative clinical isolates to screen for DNA gyrase A-mediated quinolone resistance. The results show that the technique is simple and applicable to a wide range of Gram-negative species including E. coli, Enterobacter cloacae, Klebsiella aerogenes, Morganella morganii, Proteus mirabilis, Pseudomonas aeruginosa, Campylobacter jejuni and Neisseria gonorrhoeae. The use of an arithmetical MIC series of dilutions (as opposed to standard geometrical ones) was found to be essential during screening for the detection of altered gyrase A. The observations were consistent with the suggestion that DNA gyrase is highly conserved among different species of bacteria and that gyrase A-mediated resistance can occur in all.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310671     DOI: 10.1093/jac/29.1.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Correlation between gyrA and CmeR Box Polymorphism and Fluoroquinolone Resistance in Campylobacter jejuni Isolates in China.

Authors:  Tengfei Zhang; Yiluo Cheng; Qingping Luo; Qin Lu; Jun Dong; Rongrong Zhang; Guoyuan Wen; Honglin Wang; Ling Luo; Hongcai Wang; Guoping Liu; Huabin Shao
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Cloning of multidrug resistance gene pqrA from Proteus vulgaris.

Authors:  H Ishida; H Fuziwara; Y Kaibori; T Horiuchi; K Sato; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

3.  Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.

Authors:  Xiaolei Yu; Milorad Susa; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 4.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.